Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients
NCT00574743
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
162
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Transplantation
Interventions
DRUG:
Enteric-coated Mycophenolate Sodium
Sponsor
Novartis Pharmaceuticals